← Back to front page
United States · Financial press · Investor's Business Daily

The Big Caveat Behind Bristol Myers' Sales Guidance Boost

Published by Investor's Business Daily · United States 3 h ago

Bristol Myers Squibb stock rose Thursday despite a "mixed bag" performance that included a miss from its biggest cancer drug. The post The Big Caveat Behind Bristol Myers' Sales…

Read the full article on Investor's Business Daily Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investors.com)

Also worth reading

The Wall Street Journal

ING Launches Buyback But Flags Job Cuts and Unit Restructuring

 Barron's

Fortinet Stock Sinks. Analysts Say a Key Revenue Driver May Have Peaked.